Krishna Institute of Medical Sciences Ltd

Krishna Institu. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Krishna Institute of Medical Sciences Ltd

₹ 1,330 0.64%
24 Mar - close price
kimshospitals.com BSE: 543308 NSE : KIMS
About

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

Key Points

Regional Leadership
KIMS is one of the largest corporate healthcare groups in Andhra Pradesh (AP) and Telangana in terms of the number of patients treated and treatments offered. It provides multidisciplinary integrated healthcare services, with a focus on primary, secondary & tertiary care in tier 2-3 cities and primary, secondary, tertiary, and quaternary healthcare in tier 1 cities. [1]

Website BSE NSE
  • Market Cap ₹ 10,643 Cr.
  • Current Price ₹ 1,330
  • High / Low ₹ 1,669 / 1,113
  • Stock P/E 34.0
  • Book Value ₹ 196
  • Dividend Yield 0.00 %
  • ROCE 34.1 %
  • ROE 29.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 59.4% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.9%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
201 410 361 359 473 412 394 372 496 564 562
165 268 268 258 330 283 264 259 358 412 411
Operating Profit 36 141 93 101 144 129 130 114 137 152 151
OPM % 18% 34% 26% 28% 30% 31% 33% 31% 28% 27% 27%
4 2 0 4 4 5 4 16 5 24 6
Interest 9 7 9 7 6 3 3 4 6 8 12
Depreciation 17 16 20 17 17 18 19 19 29 31 33
Profit before tax 14 119 65 81 125 113 112 107 107 137 113
Tax % 36% 25% 26% 28% 26% 26% 25% 22% 26% 23% 27%
Net Profit 9 90 48 59 92 84 84 83 79 106 82
EPS in Rs 1.49 11.21 6.55 7.45 11.14 10.21 10.14 10.08 8.74 12.13 9.49
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
512 567 664 918 1,123 1,330 1,651 1,994
403 450 593 833 872 953 1,126 1,440
Operating Profit 109 118 71 85 251 377 524 554
OPM % 21% 21% 11% 9% 22% 28% 32% 28%
5 3 37 6 5 9 27 52
Interest 37 32 88 49 44 37 22 29
Depreciation 36 35 40 56 71 70 73 112
Profit before tax 41 53 -20 -15 141 279 457 464
Tax % 32% 37% -126% -223% 18% 26% 25%
Net Profit 28 33 -46 -49 115 205 344 350
EPS in Rs 3.78 4.55 -6.61 -6.40 16.00 25.93 41.57 40.44
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 24%
3 Years: 22%
TTM: 22%
Compounded Profit Growth
10 Years: %
5 Years: 59%
3 Years: 108%
TTM: 1%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -1%
Return on Equity
10 Years: %
5 Years: 21%
3 Years: 27%
Last Year: 30%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
70 72 50 74 74 78 80 80
Reserves 193 255 -209 466 523 786 1,307 1,486
256 280 753 336 369 316 257 477
146 167 359 237 228 253 260 651
Total Liabilities 665 774 954 1,114 1,194 1,433 1,904 2,694
515 518 755 863 916 931 1,005 1,780
CWIP 2 64 0 0 2 9 21 126
Investments 11 14 0 0 0 0 332 60
137 177 199 250 276 493 546 728
Total Assets 665 774 954 1,114 1,194 1,433 1,904 2,694

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
95 82 106 134 202 356 324
-41 -100 -64 -110 -125 -354 -412
-65 24 -39 -27 -44 10 61
Net Cash Flow -11 5 3 -3 32 12 -26

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 47 59 59 49 43 30 28
Inventory Days 36 43 46 47 44 30 37
Days Payable 194 207 215 181 177 167 133
Cash Conversion Cycle -111 -105 -110 -85 -91 -106 -67
Working Capital Days 11 26 -315 -7 -10 -6 4
ROCE % 15% 11% 5% 20% 30% 34%

Shareholding Pattern

Numbers in percentages

1 recently
Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
38.84 38.84 38.84 38.84 38.84 38.85 38.85
11.57 9.90 8.44 8.91 8.36 10.17 20.50
16.28 18.64 20.87 21.02 22.78 27.97 28.32
33.31 32.61 31.84 31.23 30.01 23.01 12.34

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls